Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2alpha
- PMID: 9665461
- PMCID: PMC1852948
- DOI: 10.1016/s0002-9440(10)65541-1
Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2alpha
Abstract
Hemangioblastomas, the most frequent manifestation of the hereditary von Hippel-Lindau disease (VHL), are highly vascularized tumors of the central nervous system. In previous studies, the endothelial-specific mitogen vascular endothelial growth factor (VEGF) was shown to be up-regulated in the stromal cells, the putative neoplastic cells in hemangioblastomas. Therefore, it was suggested that secretion of VEGF by stromal cells is the pathogenetic cause of the vascular lesions in hemangioblastomas. The novel basic helix loop helix transcription factor HRF/HIF-2alpha is a candidate regulator of VEGF expression during development. We therefore investigated expression of HRF/HIF-2alpha in hemangioblastomas and found the overexpression of VEGF mRNA in stromal cells to be highly correlated with elevated expression levels of HRF/HIF-2alpha mRNA. This finding is suggestive for a role of HRF in VEGF-dependent vascular growth in hemangioblastomas and could provide a link between transcriptional activation of the VEGF gene and loss of function of the VHL gene product.
Figures


Similar articles
-
Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.Oncogene. 2000 Nov 16;19(48):5435-43. doi: 10.1038/sj.onc.1203938. Oncogene. 2000. PMID: 11114720
-
Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene.J Neuropathol Exp Neurol. 1997 Nov;56(11):1242-52. doi: 10.1097/00005072-199711000-00009. J Neuropathol Exp Neurol. 1997. PMID: 9370235
-
Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function.Blood. 1998 Nov 1;92(9):3388-93. Blood. 1998. PMID: 9787178
-
Pathology, genetics and cell biology of hemangioblastomas.Histol Histopathol. 1996 Oct;11(4):1049-61. Histol Histopathol. 1996. PMID: 8930647 Review.
-
Von hippel-lindau disease: a genetic and clinical review.Semin Ophthalmol. 2013 Sep-Nov;28(5-6):377-86. doi: 10.3109/08820538.2013.825281. Semin Ophthalmol. 2013. PMID: 24138046 Review.
Cited by
-
Retinal Diseases Regulated by Hypoxia-Basic and Clinical Perspectives: A Comprehensive Review.J Clin Med. 2021 Nov 24;10(23):5496. doi: 10.3390/jcm10235496. J Clin Med. 2021. PMID: 34884197 Free PMC article. Review.
-
Versatile roles of annexin A4 in clear cell renal cell carcinoma: Impact on membrane repair, transcriptional signatures, and composition of the tumor microenvironment.iScience. 2025 Mar 11;28(4):112198. doi: 10.1016/j.isci.2025.112198. eCollection 2025 Apr 18. iScience. 2025. PMID: 40212597 Free PMC article.
-
EPAS1 mRNA in plasma from colorectal cancer patients is associated with poor outcome in advanced stages.Oncol Lett. 2011 Jul;2(4):719-724. doi: 10.3892/ol.2011.294. Epub 2011 Apr 28. Oncol Lett. 2011. PMID: 22848255 Free PMC article.
-
Downregulation of lncRNA APCDD1L-AS1 due to DNA hypermethylation and loss of VHL protein expression promotes the progression of clear cell renal cell carcinoma.Int J Biol Sci. 2022 Mar 21;18(6):2583-2596. doi: 10.7150/ijbs.71519. eCollection 2022. Int J Biol Sci. 2022. PMID: 35414787 Free PMC article.
-
The VHL tumor suppressor and HIF: insights from genetic studies in mice.Cell Death Differ. 2008 Apr;15(4):650-9. doi: 10.1038/sj.cdd.4402313. Epub 2008 Jan 25. Cell Death Differ. 2008. PMID: 18219317 Free PMC article. Review.
References
-
- Wizigmann-Voos S, Plate KH: Pathology, genetics and cell biology of hemangioblastomas. Histol Histopathol 1996, 11:1049-1061 - PubMed
-
- Wizigmann-Voos S, Breier G, Risau W, Plate KH: Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 1995, 55:1358-1364 - PubMed
-
- Ferrara N, Houck K, Jakeman L, Leung DW: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992, 13:18-32 - PubMed
-
- Millauer B, Wizigmann Voos S, Schnürch H, Martinez R, Moller NP, Risau W, Ullrich A: High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993, 72:835-846 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources